The Patent Finder
US

Solvent/Polymer Solutions as Suspension Vehicles

US 8,114,437 In force
OverviewFamilyAssignmentsSources & methods

Term ends Aug 8, 2027 · High confidence

Filed Feb 3, 2006 as application 11/347,562 · Granted Feb 14, 2012
Base term plus 1502 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2006 2027
Clock starts
Feb 3, 2006
Term ends
Aug 8, 2027
Granted
Feb 14, 2012
base term patent term adjustment fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
1,502
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 7,682,356.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
23
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 1502 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 3, 2006, when this application, 11/347,562, was filedFeb 3, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+1502 days, USPTO patent term adjustment recordMar 16, 2030High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,682,356)capped to Aug 8, 2027High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderAug 8, 2027High confidence

This family

US 8,114,437this patent
Aug 2027
Aug 2027
US 8,052,996In force
no later than Feb 2029
no later than Feb 2029
US 8,299,025Term ended
Feb 2026
Feb 2026
US 8,211,467Term ended
Feb 2026
Feb 2026
US 8,940,316In force
no later than Jan 2029
no later than Jan 2029
US 8,206,745Term ended
Feb 2026
Feb 2026
US 8,158,150Term ended
Feb 2026
Feb 2026
US 8,273,365Term ended
Feb 2026
Feb 2026
8 of 23 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 10, 2006
Reel 17885, frame 733
Rohloff, Catherine M.; Chen, Guohau; Luk, Andrew S.; Ayer, Rupal A.; Houston, Paul R.; Desjardin, Michael A.; Zamora, Pauline; Lam, StanAlza CorporationAssignment of Assignor's Interest
Dec 13, 2007
Reel 20252, frame 143
Alza CorporationIntarcia Therapeutics, Inc.Assignment of Assignor's Interest
Sep 8, 2010
Reel 24953, frame 525
Intarcia Therapeutics, Inc.Oxford Finance Corporation; Silicon Valley BankSecurity Agreement
Sep 8, 2010
reel/frame not recorded
Intarcia Therapeutics, Inc.Oxford Finance CorporationSecurity Agreement
Sep 8, 2010
reel/frame not recorded
Intarcia Therapeutics, Inc.Silicon Valley BankSecurity Agreement
Sep 23, 2011
Reel 26962, frame 62
Oxford Finance Corporation; Silicon Valley BankIntarcia Therapeutics, Inc.Release of Security Interest
Nov 14, 2012
Reel 29299, frame 678
Intarcia Therapeutics, Inc.U.S. Bank National Association, as Collateral AgentSecurity Agreement
Oct 23, 2015
Reel 36942, frame 544
U.S. Bank National Association, as Collateral AgentIntarcia Therapeutics, Inc.Release of Security Interest
Oct 9, 2019
Reel 50673, frame 20
Intarcia Therapeutics, Inc.; Intarcia Ireland LimitedMidcap Financial Trust, As AgentSecurity Interest
Oct 23, 2019
Reel 50801, frame 267
Intarcia Therapeutics, Inc.Baupost Private Investments Bviv-3, L.L.C., as Collateral AgentSecurity Interest
Jan 29, 2020
Reel 51739, frame 453
Baupost Private Investments Bviv-3, L.L.C. as Collateral AgentIntarcia Therapeutics, Inc.Release of Security Interest
Apr 17, 2020
Reel 52433, frame 1
Midcap Financial Trust, As AgentIntarcia Therapeutics, Inc.; Intarcia Ireland LimitedRelease of Security Interest
Apr 17, 2020
reel/frame not recorded
Midcap Financial Trust, As AgentIntarcia Therapeutics, Inc.Release of Security Interest
Apr 17, 2020
reel/frame not recorded
Midcap Financial Trust, As AgentIntarcia Ireland LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited